Self-assembling human skeletal organoids for disease modeling and drug testing

Area of Science:

• Biotechnology
• Regenerative Medicine
• Skeletal Biology

Background:

• Skeletal conditions pose significant global health challenges.
• Developing effective therapies is hindered by the lack of accurate preclinical models.
• Existing models often fail to replicate the complexity of native bone and cartilage tissues.

Purpose of the Study:

• To present a novel whole-organ approach for modeling human bone and cartilage tissues.
• To create self-assembling skeletal organoids that mimic native tissue cellularity and organization.
• To utilize these organoids for disease modeling and therapeutic testing.

Main Methods:

• Development of self-assembling bone and cartilage organoids.
• Assessment of osteogenesis, microvessel formation, cartilage development, and maturation.
• Generation of hybrid skeletal organoids for "mini joint" cultures.
• Modeling of inflammatory disease and testing of Adenosine (A2A) receptor agonists.

Main Results:

• Bone organoids exhibited osteogenesis and microvessel formation.
• Cartilage organoids demonstrated development and maturation.
• Hybrid organoids showed spontaneous polarization of bone and cartilage components.
• Successful modeling of inflammatory disease and therapeutic agent efficacy using "mini joint" cultures.

Conclusions:

• Skeletal organoids provide an accurate model for human bone and cartilage development.
• These organoids effectively mimic native tissue microenvironments.
• Skeletal organoids are a viable platform for preclinical disease modeling and therapeutic agent screening.